跳至主要内容
临床试验/CTRI/2016/09/007241
CTRI/2016/09/007241招募中4 期

Prospective study of outcomes following neoadjuvant chemotherapy (Gemcitabine and Cisplatin) in patients of muscle invasive urinary bladder cancer

KING GEORGE MEDICAL UNIVERSITY0 个研究点目标入组 25 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1.Performance Status (Eastern Cooperative Oncology Group - ECOG) 0 â?? 2
  • 2.Histologically confirmed muscle-invasive bladder cancer
  • 3.Resectable disease at diagnosis (clinical stages T2 - T4a, N0 - 1, M0) transitional cell carcinoma of the bladder
  • 4.Patients should have adequate bone marrow function (white blood cell count > 3.0 x 109/L, platelet count > 150 x 109/L)
  • 5.Renal function (serum creatinine < 2.0 mg/dL)

排除标准

  • 1.No history of previous chemotherapy or radiotherapy.
  • 2.Patients with previous history of other cancers

研究者

相似试验

Role of chemotherapy in high grade urinary bladder... | 临床试验